2024-515827-12-00CompletedPhase 1
Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Jan 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 4 Jul 2024
- Start date
- 28 Jan 2020
- Lead sponsor
- AvenCell Europe GmbH
- Diseases
- Acute myeloid leukemia
- EU CT number
- 2024-515827-12-00
- EudraCT number
- 2019-001339-30
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 10 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (10)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Aachen AöR | Aachen | Germany | Completed |
| Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR | Dresden | Germany | Completed |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | Completed |
| Universitaet Leipzig | Leipzig | Germany | Completed |
| Philipps-Universitaet Marburg | Marburg | Germany | Completed |
| Klinikum der Universitaet Muenchen AöR | Munich | Germany | Completed |
| Universitaetsklinikum Ulm AoR | Ulm | Germany | Completed |
| Universitaetsklinikum Wuerzburg AöR | Wuerzburg | Germany | Completed |
| Universitair Medisch Centrum Groningen | Groningen | Netherlands | Completed |
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Rotterdam | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.